Private Trust Company’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-18
Closed -$1.89K 2533
2025
Q1
$1.89K Buy
+18
New +$1.89K ﹤0.01% 2266